Evidence map›Paper›PMID 42706267›Full record

ArticleNature communications2026

Rab4b controls hepatic glucose production during fasting through glycophagy.

Marion Dussot, Lucie Le Parc, Sihame Sabbane, Alycia Zedda, Abderrahman Chafik, Alexandre Gallerand, Karine Dumas, Stéphanie Bonnafous, Yun Kwon, Sandra Lacas-Gervais and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marion Dussot *Université Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Lucie Le Parc *Université Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Sihame SabbaneUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Alycia ZeddaUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Abderrahman ChafikUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Alexandre GallerandUniversité Côte d'Azur, CNRS, Adipo-Cible Research Study Group, LP2M, Team "Cellules myéloïdes et métabolisme", Nice, France.ORCID http://orcid.org/0000-0002-3127-1343
Karine DumasUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Stéphanie BonnafousUniversité Côte d'Azur, CHU, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Chronic liver diseases associated with obesity and alcohol ", Nice, France.
Yun KwonEuropean Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Sandra Lacas-GervaisUniversité Côte d'Azur, CCMA, Centre Commun de Microscopie Appliquée (CCMA), Nice, France.
Charlotte Hinault BoyerUniversité Côte d'Azur, Centre Hospitalier Universitaire de Nice, Laboratoire de Biochimie-Hormonologie, Hôpital Pasteur, Nice, France.
Giulia ChinettiUniversité Côte d'Azur, CNRS, Adipo-Cible Research Study Group, LP2M, Team "Cellules myéloïdes et métabolisme", Nice, France.
Sophie Giorgetti-PeraldiUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.
Philippe GualUniversité Côte d'Azur, CHU, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Chronic liver diseases associated with obesity and alcohol ", Nice, France.
Stoyan IvanovUniversité Côte d'Azur, CNRS, Adipo-Cible Research Study Group, LP2M, Team "Cellules myéloïdes et métabolisme", Nice, France.ORCID http://orcid.org/0000-0002-0527-2297
Anja ZeigererEuropean Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4072-0566
Jean-François TantiUniversité Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France.ORCID http://orcid.org/0000-0003-1782-1318
Mireille Cormont *Université Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France. mireille.cormont@univ-cotedazur.fr.ORCID http://orcid.org/0000-0001-6918-2410
Jerome Gilleron *Université Côte d'Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team "Insulin Resistance in Obesity and Type 2 Diabetes", Nice, France. jerome.gilleron@univ-cotedazur.fr.ORCID http://orcid.org/0000-0002-6389-8685

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-11-LABX-0028-01Agence Nationale de la Recherche (French National Research Agency) ANR-15-IDEX-01Agence Nationale de la Recherche (French National Research Agency) ANR18-CE14-0035-01-GILLERONAgence Nationale de la Recherche (French National Research Agency) ANR-20-CE13-0021Agence Nationale de la Recherche (French National Research Agency) ANR-23-CE14-0048-01Agence Nationale de la Recherche (French National Research Agency) ANR-25-CE14-3253-01
6 · The paper itself

Abstract

Hepatic glucose production, essential for maintaining glycemia, is often altered in metabolic-associated fatty liver and glycogen storage diseases. Therefore, understanding the mechanisms that regulate the glucose production by hepatocyte is pivotal. Recent studies have identified endocytic trafficking as a key modulator of liver glucose production. Particularly, its role in directing protein trafficking toward lysosomal degradation influences gluconeogenesis. However, the contribution of endocytic recycling to liver glucose production remains yet poorly understood. Here, we demonstrate that hepatocyte-specific disruption of endocytic recycling, achieved through Rab4b knockout in male, leads to fasting hyperglycemia. Mechanistically, hepatocytes lacking Rab4b exhibit an increased capacity to produce glucose independently of gluconeogenesis by depleting their glycogen stores. This is driven by enhanced glycophagy, leading to excessive glucose release and fasting hyperglycemia. Notably, liver Rab4b expression also correlates with glycemia in both mice and human, highlighting a critical role of Rab4b-dependent endocytic recycling in regulating blood glucose homeostasis during fasting.

Indexed as

FastingGlucoseLiverrab4 GTP-Binding ProteinsAnimalsBlood GlucoseEndocytosisGluconeogenesisGlycogenHepatocytesHumansHyperglycemiaMaleMiceMice, Inbred C57BLMice, KnockoutBlood GlucoseGlucoseGlycogenrab4 GTP-Binding Proteins

Identifiers

PMID42706267
PMCPMC13550640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.